Catherine Pearce - Jan 12, 2022 Form 4/A - Amendment Insider Report for CinCor Pharma, Inc. (CINC)

Role
Chief Operating Officer
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Jan 12, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/13/2022, 03:21 PM
Date Of Original Report
Jan 10, 2022
Previous filing
Jan 13, 2022
Next filing
Jan 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Restricted Stock Units Award $0 +26.5K $0.00 26.5K Jan 12, 2022 Common Stock 26.5K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
F2 This Form 4 amendment is being filed to correct the original Form 4 filed on January 10, 2022. The Transaction Date was stated incorrectly on the original Form 4.
F3 The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.